Laura Tam Clinical Oncology Society of Australia Annual Scientific Meeting 2018

Abstracts this author is presenting:

• Exploring the feasibility of rechallenging immunotherapy in lung and melanoma patients following a grade 3-4 immunotherapy-related adverse event.  — Poster Session 2